BESSEMER GROUP INC

Position in GRFS — Grifols SA

CIK 1054074 WOODBRIDGE, NJ

Position in GRFS

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$3,066

+$3,062 QoQ

Shares Held

511

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#138

of 164 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BESSEMER GROUP INC holds $2,467,290,706 across 16 Drug Manufacturers - General names. GRFS ranks #16 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	923,815	$1,108,051,512
2	ABBV	AbbVie Inc.	2,954,184	$743,390,856
3	GILD	Gilead Sciences, Inc.	1,444,022	$182,437,735
4	MRK	Merck & Co., Inc.	1,080,415	$138,833,324
5	JNJ	Johnson & Johnson	539,958	$137,133,128
6	PFE	Pfizer Inc	5,067,281	$122,020,120
7	AMGN	Amgen Inc	31,001	$11,226,079
8	NVS	Novartis AG	64,977	$10,183,191

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,066	511	0.0%	Shares	Defined	2026-08-12
2026-03-31	$4	511	-53.5%	Shares	Defined	2026-05-06
2025-12-31	$9,537	1,098	+10.1%	Shares	Defined	2026-02-05
2025-09-30	$9,154	997	-91.6%	Shares	Defined	2025-11-05
2025-06-30	$106,157	11,821	+1693.8%	Shares	Defined	2025-08-01
2025-03-31	$4,131	659	+744.9%	Shares	Defined	2025-04-23
2024-12-31	$1	78	0.0%	Shares	Defined	2025-02-13
2024-09-30	$1	78	-87.6%	Shares	Defined	2024-11-12
2022-03-31	$7,335	628	-54.5%	Shares	Other	2022-05-12
2021-12-31	$15,485	1,379	+96.7%	Shares	Defined	2022-01-27
2021-09-30	$10,241	701	0.0%	Shares	Defined	2021-11-12
2021-06-30	$12,161	701	-37.3%	Shares	Defined	2021-08-06
2021-03-31	$19,330	1,118	+78.0%	Shares	Defined	2021-05-13
2020-12-31	$11,580	628	—	Shares	Other	2021-02-09
No filing history on record for this holder in this stock.